Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
National Institutes of Health · Cooperative Agreement
Overview
Supports cancer risk and early-detection biomarker research using biospecimens from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Projects must use the PLCO collection and exploit its distinctive samples or associated data.
Eligibility
Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply. Research must use PLCO biospecimens.
Other deadlines
Next application deadline, including permitted resubmissions: 9 October 2026. Submit by 17:00 local time of the applicant organisation. Call expiration: 9 October 2027. This is separate from the application deadline.
Contact
National Institutes of Health · [email protected]
Keywords
Health sciences